ViraCyte
New Brighton, US · Founded 2018 · Delaware corporation · 1 known investors
Find your way into ViraCyte
44 people in our graph share verified history with the ViraCyte team — schools, employers, funds. One of them is your warm intro.
Bret L. Bostwickunlockedknows Juan Vera · together at Baylor College of Medicine (overlapped)
×10knows the team · via Baylor College of Medicine
knows the team · via ViraCyte
Founders & leadership
ViraCyte was founded in 2018 by Juan Vera and Malcom Brenner.
JV
Juan VerainCo-founderJuan Vera trained as a medical surgeon and spent 12 years at Baylor College of Medicine's Center for Cell and Gene Therapy developing T cell therapies and manufacturing processes, including work with the G-Rex cell culture platform for large-scale T cell production. He has collaborated with Celgene and Bluebird Bio on CAR T cell therapy development and has experience translating therapeutic candidates from research to clinical manufacturing.
MB
Malcom BrennerCo-founder
DH
David HallalExecutive
VS
Vikas SinhaExecutive
JW
John WilsonNamed on SEC filing
Board
AG
Investors · 1
Reported raises · per SEC filings
Form D private placements$151.3M disclosed across 2 rounds · 2018–2019
▶$121.3MraisedMay 2019 · 47 investors · BiotechnologyRule 506(b)
▶$121.3MraisedMay 2019 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David HallalExecutive Officer, Director
- Vikas SinhaExecutive Officer, Director
- John WilsonDirector
- Morana Jovan-EmbiricosDirector
- Malcom BrennerDirector
- Ansbert GadickeDirector
- Juan VeraDirector
- Offering amount
- $121.3M
- Amount sold
- $121.3M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$30MraisedOct 2018 · 1 investors · BiotechnologyRule 506(b)
▶$30MraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ansbert GadickeDirector
- Juan VeraDirector
- John WilsonDirector
- David HallalExecutive Officer, Director
- Vikas SinhaExecutive Officer, Director
- Malcom BrennerDirector
- Offering amount
- $50M
- Amount sold
- $30M
- Proceeds to insiders
- $6.8M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded ViraCyte?
- ViraCyte was founded by Juan Vera, Malcom Brenner in 2018.
- Who are ViraCyte's investors?
- ViraCyte's investors include MPM BioImpact.
- How much funding has ViraCyte raised?
- ViraCyte has disclosed $151.3M raised across 2 rounds.
- Where is ViraCyte headquartered?
- ViraCyte is headquartered in New Brighton, US.